palmidrol has been researched along with 4-cyano-1-(2,4-dichlorophenyl)-5-(4-methoxyphenyl)-n-(piperidin-1-yl)-1h-pyrazole-3-carboxamide in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bailey, CR; Carson, RE; Corsi-Travali, S; Gujarro-Anton, A; Henry, S; Huang, Y; Lin, SF; Najafzadeh, S; Neumeister, A; Normandin, MD; Pietrzak, RH; Piomelli, D; Potenza, MN; Ropchan, J; Zheng, MQ | 1 |
1 other study(ies) available for palmidrol and 4-cyano-1-(2,4-dichlorophenyl)-5-(4-methoxyphenyl)-n-(piperidin-1-yl)-1h-pyrazole-3-carboxamide
Article | Year |
---|---|
Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study.
Topics: Adult; Amides; Analysis of Variance; Arachidonic Acids; Brain; Endocannabinoids; Ethanolamines; Female; Glycerides; Humans; Hydrocortisone; Imidazoles; Logistic Models; Male; Palmitic Acids; Piperidines; Polyunsaturated Alkamides; Pyrazoles; Radionuclide Imaging; Receptor, Cannabinoid, CB1; Stress Disorders, Post-Traumatic; Young Adult | 2013 |